As the previous area explains, these approaches are resilient, quick, reasonably cheap, and relatively simple to operate, generating them desirable to regulators enthusiastic about checking drug top quality. Box 6-three describes the Chinese regulatory authority's cellular verification labs. Deal verification technologies could also aid in industry